OT Staff Reports

Articles

Targeting neurodegenerative diseases with risuteganib as treatment therapy

May 03, 2021

Glenn J. Jaffe, MD, discusses the key points of his virtual presentation on targeting neurodegenerative diseases with risuteganib, minimizing damage to the retina when compromised, and the need for newer treatment therapies to target different pathways.